What's Trending in Stocks Right Now
Discover which stock market news stories are capturing the most attention today. This page shows you the most-viewed articles on StockTitan, updated every minute based on real visitor traffic. See what tens of thousands of traders and investors are reading right now.
Why this matters: When a news story suddenly gets massive readership, it often indicates significant market interest in that stock or sector. By tracking the most popular articles, you can quickly identify which companies and events are drawing investor attention and potentially moving markets.
This isn't editorial content or sponsored placement—it's based purely on reader activity. Every story below earned its position through actual page views from real visitors, making this an authentic snapshot of what the trading community finds most interesting. Whether it's earnings reports, FDA decisions, merger news, or market analysis, the most-read stories rise to the top.
Updated Every Minute: Market sentiment shifts quickly. This ranking is recalculated every 60 seconds to reflect the latest reading trends. What's trending now could be completely different in an hour as new stories break and capture attention.
Quantum Cyber (Nasdaq: QUCY) signed an IP License Agreement with BP United, securing an exclusive license to BP United’s autonomous drone technology, including a sky defense platform.
The deal includes a commercial supply arrangement for tested, ready-to-deploy systems with autonomous takeoff, navigation, landing, encrypted communications, and ranges over 25 km for surveillance, interdiction, and payload delivery. Quantum Cyber aims to build a system-of-systems autonomous defense platform as the Trump administration seeks about $55 billion for drone and autonomous warfare in the 2027 U.S. defense budget, up from roughly $225 million, signaling a major expansion in AI-enabled autonomous systems.
- Exclusive license to BP United autonomous drone technology portfolio, including sky defense platform
- Commercial supply arrangement for tested, ready-to-deploy autonomous systems
- Drone platform range exceeds 25 km with fully autonomous flight and encrypted communications
- Positioning toward fast-growing autonomous warfare segment tied to proposed $55 billion U.S. budget
- Management highlights pathway from platform assembly to potential revenue generation
- None.
Nebius (NASDAQ: NBIS) reported unaudited Q1 2026 results. Revenue rose to $399.0 million, up 684% year over year. Net income from continuing operations was $621.2 million versus a $104.3 million loss in Q1 2025. Adjusted EBITDA reached $129.5 million.
Adjusted net loss was $100.3 million. Cash provided by operating activities was $2,258.0 million, while purchases of property, equipment and intangibles were $2,472.9 million. Total operating costs and expenses were $527.0 million. Nebius also secured up to 1.2 GW of power and land for a new AI factory in Pennsylvania. Shares outstanding at March 31, 2026 were 253.9 million.
- Revenue increased to $399.0 million in Q1 2026, up 684% year over year
- Net income from continuing operations improved to $621.2 million from a $104.3 million loss
- Adjusted EBITDA swung to a $129.5 million profit from a $53.7 million loss
- Operating cash flow from continuing operations reached $2,258.0 million versus $(184.1) million a year earlier
- Total operating costs fell to 132% of revenue from 336% despite rising in absolute terms
- Secured up to 1.2 GW of power and land for a new Pennsylvania AI factory
- Adjusted net loss widened to $100.3 million from $83.6 million
- Total operating costs and expenses increased to $527.0 million, up 208% year over year
- Purchases of property, equipment and intangibles rose to $2,472.9 million, a 355% increase
- Depreciation and amortization grew to $212.0 million, 53% of revenue
- Total share-based compensation expense doubled to $35.3 million, 7% of operating expenses
Eos Energy (NASDAQ: EOSE) reported Q1 2026 revenue of $57.0 million, up 445% year-over-year, with record production and over 6.0 GWh of discharged energy. Despite a $44.4 million gross loss, net income reached $508.9 million due to non-cash fair value gains.
The company reaffirmed 2026 revenue guidance of $300–$400 million, expanded its commercial pipeline to $24.3 billion with a $644.6 million backlog, and formed Frontier Power USA with Cerberus, anchored by a planned $100 million equity commitment and a targeted ~$150 million contribution from Eos.
- Q1 2026 revenue $57.0 million, up 445% year-over-year
- Net income attributable to shareholders $508.9 million from non-cash fair value change
- Adjusted EBITDA loss margin improved 294 percentage points year-over-year
- Total cash, including restricted, of $472.4 million at March 31, 2026
- Commercial pipeline $24.3 billion, up 56% year-over-year
- Orders backlog $644.6 million representing 2.6 GWh as of March 31, 2026
- 2 GWh firm capacity reservation agreement with Frontier Power USA expands backlog
- Reaffirmed 2026 revenue guidance of $300–$400 million
- Formation of Frontier Power USA with $100 million Cerberus equity commitment
- Targeted ~$150 million Eos contribution to Frontier Power USA, subject to funding
- Record quarterly production and more than 6.0 GWh discharged energy from Eos technology
- Second battery module line at Thorn Hill on schedule for production by end of Q2 2026
- Q1 2026 gross loss of $44.4 million
- Adjusted gross loss of $39.0 million in the quarter
- Adjusted EBITDA loss of $68.0 million in Q1 2026
- Eos targeted ~$150 million contribution to Frontier Power USA depends on ability to raise funding
SRx Health Solutions (NYSE American: SRXH) and EMJ Crypto Technologies announced an investment of more than 10% of SRXH's investable capital into Astro Investment XVII, an Astro Capital affiliate SPV holding investments in SpaceX and other AI and space companies.
The company highlighted AI and space as long-term growth themes and reported filing a Form S-4 Registration Statement with the SEC for its proposed merger with EMJ Crypto.
- Commits >10% of investable capital to AI and space via Astro Investment XVII
- Gains exposure to SpaceX and other AI/space companies through Astro Capital-managed SPV
- Form S-4 Registration Statement filed for proposed merger with EMJ Crypto Technologies
- None.
Wellgistics Health (NASDAQ:WGRX) announced a pilot collaboration with Kare PharmTech and Kare Clinicals to integrate its MSO infrastructure for chronic care management (CCM) and remote patient monitoring (RPM) across multiple provider offices.
The U.S. RPM market is cited at $14 billion, projected to reach ~$29 billion by 2030 at a 12.6% CAGR. The pilot has generated 1,500+ claims to date and is intended as a base for broader provider expansion. Wellgistics plans to leverage its network of 6,500+ independent pharmacies to help identify eligible patients and support engagement, while participating pharmacists may gain access to new clinical service revenue opportunities.
- None.
- None.
Eos Energy (NASDAQ: EOSE) and Cerberus Capital Management plan to capitalize Frontier Power USA, a new independent developer and investment platform for long-duration battery energy storage using Eos’ Z3 zinc-bromide technology.
Key elements include a firm 2 GWh capacity reservation, a 15-year technology performance insurance framework with up to ~$1.5 billion in policy capacity, and a $100 million Cerberus equity commitment. Eos intends to fund its equity in Frontier Power USA via a rights offering targeting about $150 million, allowing existing shareholders to maintain proportional economic participation, subject to board, shareholder, and lender consents.
- Firm 2 GWh capacity reservation agreement expanding Eos’ March 31, 2026 backlog
- Up to ~$1.5 billion, 15-year technology performance insurance framework with Ariel Green
- Cerberus $100 million equity commitment to anchor Frontier Power USA
- Cerberus extends existing Eos lock-up through year-end 2026
- Planned ~$150 million rights offering to fund Eos equity in Frontier Power USA
- Project-level capital separated from Eos corporate balance sheet for future developments
- Eos rights offering terms not yet determined and subject to multiple approvals and consents
- Planned rights offering may create dilution risk for non-participating Eos shareholders
- Cerberus expected to receive controlling equity in Frontier Power USA
- Funding of Cerberus’s $100 million equity commitment subject to closing conditions
Infleqtion (NYSE: INFQ) introduced Quantum Spectrum, an atom-based RF sensing platform that it describes as the first fundamental shift in RF sensing architecture in decades. The technology uses Rydberg atoms to detect and authenticate signals across hertz to terahertz, targeting contested, jammed, or GPS-denied environments.
According to Infleqtion, active defense programs in the U.S., U.K., and Australia and partnerships with Dell Federal, L3Harris, and SAIC support development toward deployable systems and future commercial uses in aviation, energy grids, telecommunications, and counter‑drone applications.
- New Quantum Spectrum category within quantum sensing based on atom-based RF detection
- Active defense field programs in United States, United Kingdom, and Australia
- Partnerships with integrators including Dell Federal, L3Harris, and SAIC
- RIQER, QuDiFi, and QOBRA projects advance toward deployable quantum RF systems
- McKinsey estimates quantum sensing market at approximately $31 billion by 2040
- Company notes substantial contracted positions and near-term defense revenue potential
- Quantum Spectrum remains in prototype, field trial, and ruggedization stages
- Commercial applications are described as potential and near-term, not yet realized products
Chegg (NYSE: CHGG) announced an expansion into AI model training and evaluation, using its proprietary academic content, especially in STEM, and a calibrated network of subject matter experts. The company will provide high-quality training data, reinforcement learning from human feedback, and content licensing to AI labs, including elite technology organizations.
- None.
- None.
Humacyte (Nasdaq:HUMA) reported first quarter 2026 results and a business update. Symvess sales reached $0.5 million (29 units), up from $0.1 million (5 units) a year earlier. Contract revenue fell to $2,000 from $0.4 million.
The company received a $1.475 million minimum Symvess purchase commitment in Saudi Arabia, Israeli review acceptance for Symvess, and new U.S. Department of Defense funding. An interim Phase 3 hemodialysis readout is planned for June 11, 2026. A workforce restructuring is expected to save $14.3 million through 2026, with estimated $0.8 million in one-time charges. Net loss was $17.6 million, and cash, cash equivalents and restricted cash totaled $48.9 million at March 31, 2026.
- Symvess commercial sales grew to $0.5 million (29 units) from $0.1 million (5 units) year over year
- Minimum $1.475 million Symvess purchase commitment for a clinical program in Saudi Arabia
- Israeli Ministry of Health accepted Symvess marketing authorization application with a 180-working-day review
- New U.S. Department of Defense funding to support procurement of bioengineered blood vessels
- Planned hemodialysis ATEV supplemental BLA submission in 2H 2026 following V012 and V007 data
- Workforce and cost reductions expected to deliver $14.3 million net savings during the remainder of 2026
- First quarter 2026 net loss of $17.6 million versus net income of $39.1 million in 2025
- Other net income declined to $11.3 million from $62.3 million year over year
- Research and development expenses increased to $19.5 million from $15.4 million
- Cost of goods sold rose to $2.0 million, including a $1.6 million inventory reserve
- Contract revenue decreased to $2,000 from $0.4 million in the prior-year quarter
- Workforce restructuring of about 45 employees will incur approximately $0.8 million in one-time charges